Lecap Asset Management Ltd. Buys 2,974 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Lecap Asset Management Ltd. increased its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 33.1% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 11,955 shares of the medical device company's stock after purchasing an additional 2,974 shares during the period. Lecap Asset Management Ltd.'s holdings in Cooper Companies were worth $1,099,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also recently bought and sold shares of the business. Ashton Thomas Securities LLC bought a new stake in shares of Cooper Companies during the 3rd quarter worth about $25,000. Covestor Ltd grew its position in shares of Cooper Companies by 144.9% in the third quarter. Covestor Ltd now owns 338 shares of the medical device company's stock valued at $37,000 after purchasing an additional 200 shares during the last quarter. Brown Brothers Harriman & Co. increased its stake in shares of Cooper Companies by 191.0% during the third quarter. Brown Brothers Harriman & Co. now owns 419 shares of the medical device company's stock worth $46,000 after purchasing an additional 275 shares during the period. West Financial Advisors LLC acquired a new stake in Cooper Companies during the 4th quarter worth approximately $49,000. Finally, Friedenthal Financial acquired a new stake in Cooper Companies during the 3rd quarter worth approximately $50,000. Institutional investors own 24.39% of the company's stock.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on the company. Citigroup lowered their price objective on Cooper Companies from $116.00 to $115.00 and set a "buy" rating on the stock in a research report on Friday, December 6th. Morgan Stanley lowered their price target on shares of Cooper Companies from $104.00 to $102.00 and set an "equal weight" rating on the stock in a research report on Friday, December 6th. StockNews.com downgraded shares of Cooper Companies from a "buy" rating to a "hold" rating in a report on Wednesday, December 11th. Wells Fargo & Company raised their target price on shares of Cooper Companies from $115.00 to $118.00 and gave the stock an "overweight" rating in a report on Friday, December 6th. Finally, Needham & Company LLC reiterated a "hold" rating on shares of Cooper Companies in a research report on Friday, December 6th. Three analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average price target of $117.00.

Cooper Companies Price Performance

COO traded down $0.18 during trading on Tuesday, hitting $93.45. 681,666 shares of the stock traded hands, compared to its average volume of 1,274,969. The business has a 50 day moving average price of $94.60 and a 200 day moving average price of $99.86. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.91 and a quick ratio of 1.12. The Cooper Companies, Inc. has a twelve month low of $84.76 and a twelve month high of $112.38. The company has a market cap of $18.65 billion, a price-to-earnings ratio of 47.92, a PEG ratio of 2.41 and a beta of 1.00.

Cooper Companies (NASDAQ:COO - Get Free Report) last announced its quarterly earnings data on Thursday, December 5th. The medical device company reported $1.04 earnings per share for the quarter, topping the consensus estimate of $1.00 by $0.04. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The business had revenue of $1.02 billion during the quarter, compared to the consensus estimate of $1.03 billion. During the same period in the prior year, the company earned $0.87 EPS. Cooper Companies's revenue for the quarter was up 9.8% on a year-over-year basis. Equities research analysts forecast that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.